Skip to main content

UBS Group AG

Position in INTS — Intensity Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in INTS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4
-$1,124 QoQ
Shares Held
1
-99.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 17 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. INTS ranks #547 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INTS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4 1
2026-03-31 $1,128 192
2025-12-31 $10,412 25,397
2025-09-30 $33,104 136,232
2025-06-30 $2,834 9,234
2025-03-31 $6,101 3,097
2024-12-31 $5,316 3,021
2024-09-30 $78,726 20,609
2024-06-30 $16,248 3,316
2024-03-31 $15,657 3,011
2023-12-31 $4,285 500